Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-20 Sale |
2024-11-22 4:12 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
3,650 | $25.45 | $92,893 | 319,228 (Direct) |
View |
| 2024-10-23 Sale |
2024-10-25 4:25 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
4,361 | $29.53 | $128,780 | 322,878 (Direct) |
View |
| 2024-10-16 Sale |
2024-10-18 4:28 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
2,860 | $28.79 | $82,339 | 327,239 (Direct) |
View |
| 2024-08-21 Sale |
2024-08-23 4:15 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
3,295 | $31.86 | $104,976 | 330,099 (Direct) |
View |
| 2024-07-24 Sale |
2024-07-26 4:17 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
4,015 | $27.76 | $111,456 | 333,394 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 5:42 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
2,505 | $29.69 | $74,382 | 337,409 (Direct) |
View |
| 2024-05-22 Sale |
2024-05-24 4:10 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
3,242 | $29.65 | $96,125 | 339,914 (Direct) |
View |
| 2024-04-24 Sale |
2024-04-26 5:18 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
3,963 | $28.9 | $114,531 | 343,156 (Direct) |
View |
| 2024-04-17 Sale |
2024-04-19 6:06 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
9,827 | $29.06 | $285,554 | 347,119 (Direct) |
View |
| 2024-02-22 Sale |
2024-02-23 4:18 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
2,134 | $36.15 | $77,144 | 301,968 (Direct) |
View |
| 2024-01-26 Sale |
2024-01-29 4:12 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
3,027 | $37.92 | $114,778 | 304,102 (Direct) |
View |
| 2023-11-22 Sale |
2023-11-24 2:41 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
3,252 | $32.78 | $106,598 | 307,129 (Direct) |
View |
| 2023-10-25 Sale |
2023-10-27 4:04 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
4,107 | $34.66 | $142,349 | 310,381 (Direct) |
View |
| 2023-08-24 Sale |
2023-08-25 5:05 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
12,286 | $20.3 | $249,406 | 314,488 (Direct) |
View |
| 2023-07-26 Sale |
2023-07-27 4:33 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
3,917 | $21.63 | $84,725 | 326,774 (Direct) |
View |
| 2023-04-25 Sale |
2023-04-26 4:08 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
2,633 | $16.29 | $42,892 | 330,691 (Direct) |
View |
| 2023-01-26 Sale |
2023-01-27 07:20 am |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
10,156 | $18.51 | $187,988 | 245,660 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:08 am |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
133,486 | $8.5 | $1,134,631 | 0 (Direct) |
View |
| 2021-07-19 Sale |
2021-07-20 8:45 pm |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
3,945 | $6.45 | $25,445 | 133,486 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 5:52 pm |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
6,829 | $11.13 | $76,007 | 107,431 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-04-02 Option Award |
2024-04-04 4:37 pm |
N/A 2034-04-02 |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
123,701 | $0 | 425,669 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:24 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
201,485 | $0 | 447,145 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:57 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
282,464 | $0 | 425,464 (Direct) |
View |
| 2022-01-28 Option Award |
2022-01-31 5:01 pm |
N/A 2032-01-28 |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
526,000 | $0 | 526,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:31 pm |
N/A 2031-02-28 |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
50,000 | $0 | 157,431 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:24 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
38,750 | $0 | 114,260 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 4:12 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
1,023 | $10.83 | 75,510 (Direct) |
View |